Barings’s Dr. Reddy's Laboratories RDY Stock Holding History

Barings’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,933	Closed	-$173K	–	169
2024 Q4	$173K	Buy	+10,933	New	+$164K	﹤0.01%	157

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barings's RDY Position: Q1 2025 in Review

Barings sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 10,933 shares — an estimated $173K sold.

Barings first reported a position in RDY in Q4 2024 and held it in 1 quarter. The position peaked at $173K in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

Barings reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
Barings sold 10,933 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $173K.
Barings first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 1 quarter.
Barings's Dr. Reddy's Laboratories position peaked at $173K in Q4 2024.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Barings's 13F filing for Q1 2025, filed 9 May 2025.